The Impact of Nuclear Factor Kappa B on the Response of Microglia in Spinal Cord Injuries

Iordanis Varsamos1, Christos Patilas1, Athanasios Galanis1

  • 13rd Department of Orthopedics, National and Kapodistrian University of Athens, KAT General Hospital, Athens, GRC.

Cureus
|March 24, 2025
PubMed

Insights

Nuclear factor kappa B (NF-kB) plays a complex role in microglia responses after spinal cord injury (SCI). Modulating NF-kB offers potential for reducing inflammation and promoting healing in SCI.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Spinal cord injury (SCI) causes primary and secondary damage, involving complex microglial responses.
  • Microglia, the CNS immune cells, are critical in SCI pathophysiology.
  • Nuclear factor kappa B (NF-kB) is a key mediator of inflammatory responses post-SCI.

Purpose of the Study:

  • To comprehensively review the involvement of NF-kB in microglial responses following SCI.
  • To understand the dual role of NF-kB in inflammation, damage, and repair after SCI.
  • To explore NF-kB as a potential therapeutic target for SCI.

Main Methods:

  • A systematic literature search of the PUBMED database was conducted.
  • Keywords used were: NF-kB, microglia, and spinal cord injury.
  • Inclusion criteria focused on clinical and experimental studies; systematic reviews and other study types were excluded.

Main Results:

  • NF-kB signaling significantly impacts microglial responses, influencing inflammation, tissue damage, and repair.
  • Deactivating NF-kB suppresses pro-inflammatory mediators and offers neuroprotection by reducing apoptosis.
  • NF-kB suppression promotes the M2 microglial phenotype, aiding tissue repair after SCI.

Conclusions:

  • NF-kB's role in microglia activation post-SCI is complex and context-dependent.
  • While initiating inflammation, NF-kB also contributes to tissue repair and regeneration.
  • Targeting NF-kB signaling in microglia presents a promising therapeutic strategy for SCI.